GS-100 ke rekombinant AAV9 vector e e khodišago NGLY1 gene ya motho. E hweditše leina la sehlare sa sešuana go tšwa go US Food and Drug Administration le European Medicine Agency (EMA) Kalafo e hweditše gape leina la FDA la bolwetši bja bana bjo bo sa tlwaelegago ka 2021 le leina la tsela ya ka pela ngwageng wa go feta.
#SCIENCE #Northern Sotho #CU
Read more at Clinical Trials Arena